PMGC Holdings Inc. SEC filings ELAB
PMGC Holdings Inc. has 273 filings in SEC EDGAR's recent list, going back to Oct 1, 2021. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 1, 2025 | — |
| EFFECT | Filing | Dec 1, 2025 | — |
| CORRESP | Letter to the SEC | Nov 25, 2025 | — |
| CORRESP | Letter to the SEC | Nov 25, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| EFFECT | Filing | Apr 10, 2025 | — |
| CORRESP | Letter to the SEC | Apr 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2025 | — |
| EFFECT | Filing | Feb 7, 2025 | — |
| DEFR14C | Proxy statement | Nov 25, 2024 | — |
| DEFR14C | Proxy statement | Nov 25, 2024 | — |
| SC TO-I/A | Amendment to form sc to-i | Nov 22, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 4, 2024 | — |
| SC TO-I/A | Amendment to form sc to-i | Nov 4, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2024 | — |
| SC TO-I | Issuer tender offer statement | Oct 4, 2024 | — |
| EFFECT | Filing | Sep 20, 2024 | — |
| CORRESP | Letter to the SEC | Sep 18, 2024 | — |
| CORRESP | Letter to the SEC | Sep 18, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| DEFR14C | Revised definitive information statement | Sep 6, 2024 | — |
| PRER14C | Revised preliminary proxy statement | Aug 26, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2024 | — |
| DRS | Filing | Aug 16, 2024 | — |
| PRER14C | Revised preliminary proxy statement | Aug 16, 2024 | — |
| CERT | Filing | Nov 20, 2023 | — |
| 8-A12B | For registration of certain classes | Nov 20, 2023 | — |
| SEC STAFF LETTER | Filing | Nov 13, 2023 | — |
| EFFECT | Filing | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2023 | — |
| SEC STAFF LETTER | Filing | Oct 5, 2023 | — |
| D | Filing | Sep 22, 2023 | — |
| D/A | Filing | Sep 11, 2023 | — |
| DRS/A | Filing | Aug 15, 2023 | — |
| DRSLTR | Filing | Aug 14, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2023 | — |
| DRSLTR | Filing | Jul 25, 2023 | — |
| DRS/A | Filing | Jul 25, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2023 | — |
| DRSLTR | Filing | Jun 14, 2023 | — |
| DRS/A | Filing | Jun 14, 2023 | — |
| D/A | Filing | May 31, 2023 | — |
| D | Filing | Apr 27, 2023 | — |
| D | Filing | Mar 17, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2023 | — |
| DRS | Filing | Feb 14, 2023 | — |
| D/A | Filing | Nov 1, 2022 | — |
| D | Filing | Jul 28, 2022 | — |
| D/A | Filing | Dec 10, 2021 | — |
| D/A | Filing | Oct 14, 2021 | — |
| D | Filing | Oct 1, 2021 | — |
| D | Filing | Oct 1, 2021 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newport Beach, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840563
- Former names
- Elevai Labs Inc. (until Nov 27, 2024); Reactive Medical Labs Inc. (until Oct 14, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.